Nonrulemaking

Requests that the FDA determine whether the NDA holder (Long Grove Pharmaceuticals, LLC) for Vasopressin Sodium Chloride 0.9%, 50 units/50 mL (1 unit/mL) (NDA 217766) has withdrawn the product for reasons of safety or efficacy.

Documents
3
Total comments
0
all analyzed
Comment status
Closed
Last activity
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.